FTXH

First Trust Nasdaq Pharmaceuticals ETF

Up$20.14
+$0.24
(+1.18%)
As of 6:55:00 PM EDT | 10/14/19  |  Market Closed

FTXH Trading Data

Open

$20.07

Low Price

$20.07

High Price

$20.14

Previous Last Price

$19.9

Bid Size

$0 X 0

Ask Size

$0 X 0

FTXH Portfolio Data

AUM

$7,084,000

Shares

350

PE Ratio

20.96

Price / Book Ratio

4.07

Expense Ratio

0.6

Net Asset Value

$20.24

Volume

Volume

300

Avg. Volume (YDT)

2,731

Dollar Volume

$0

Weekly Avg. Volume

1,840

Monthly Avg. Volume

1,230

Quarterly Avg. Volume

1,228

FTXH Fund Description

The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.

FTXH Chart

FTXH Summary

Fund Family

First Trust Portfolios

Tracks This Index

First Trust Nasdaq Pharmaceuticals ETF

Inception Date

2016-09-20

Asset Class

Equity

Asset Class Size

Large Cap

FTXH Classification

Region (General)

North America

Region (Specific)

US

Sector

Equity Index

Leveraged Family

FTXH Holdings

Top 10 Holdings

First Trust Nasdaq Pharmaceuticals ETF (FTXH)
0%
Zoetis Inc. (ZTS)
0%
Pfizer Inc. (PFE)
0%
Johnson & Johnson (JNJ)
0%
Merck & Co. Inc. (MRK)
0%
Abbott Laboratories (ABT)
0%
AbbVie Inc. (ABBV)
0%
Perrigo Company Plc (PRGO)
0%
The Medicines Company (MDCO)
0%
Bristol-Myers Squibb Company (BMY)
0%

Total FTXH Holdings

Total Holdings: 32

First Trust Nasdaq Pharmaceuticals ETF (FTXH)
0%
Zoetis Inc. (ZTS)
0%
Pfizer Inc. (PFE)
0%
Johnson & Johnson (JNJ)
0%
Merck & Co. Inc. (MRK)
0%
Abbott Laboratories (ABT)
0%
AbbVie Inc. (ABBV)
0%
Perrigo Company Plc (PRGO)
0%
The Medicines Company (MDCO)
0%
Bristol-Myers Squibb Company (BMY)
0%
Horizon Therapeutics Plc (HZNP)
0%
Eli Lilly and Company (LLY)
0%
Innoviva Inc. (INVA)
0%
Jazz Pharmaceuticals Plc (JAZZ)
0%
Catalent Inc. (CTLT)
0%
Corcept Therapeutics Incorporated (CORT)
0%
Endo International Plc (ENDP)
0%
Allergan Plc (AGN)
0%
Esperion Therapeutics Inc. (ESPR)
0%
Pacira BioSciences Inc. (PCRX)
0%
Heron Therapeutics Inc. (HRTX)
0%
Mylan N.V. (MYL)
0%
Zogenix Inc. (ZGNX)
0%
Blueprint Medicines Corporation (BPMC)
0%
Supernus Pharmaceuticals Inc. (SUPN)
0%
Madrigal Pharmaceuticals Inc. (MDGL)
0%
Ironwood Pharmaceuticals Inc. (IRWD)
0%
Vanda Pharmaceuticals Inc. (VNDA)
0%
Alkermes Plc (ALKS)
0%
Sage Therapeutics Inc. (SAGE)
0%
Amicus Therapeutics Inc. (FOLD)
0%
US Dollar ($USD)
0%

FTXH Technicals

Alpha

0

Beta

1.02

Leverage

Long

Standard Deviation

1

FTXH Dividends

Dividend Date

2019-09-25

Latest Dividend

0.05

Annual Dividend

0.15

Annual Dividend Rate

0.15

Annual Dividend Yield

0.76

FTXH Performance

YTD Return

4.82%

1 Year Return

-10.31%

3 Year Return

5.53%

5 Year Return

0%

10 Year Return

2.1%

FTXH Related Articles

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.